COVID-19 vaccination in Nepal

This article may need to be rewritten to comply with Wikipedia's quality standards. You can help. The talk page may contain suggestions. (January 2022)

This article needs to be updated. Please help update this article to reflect recent events or newly available information. (January 2022)

COVID-19 vaccination programme

Oxford–AstraZeneca (Covishied), the most commonly used vaccine in Nepal[1]
Date	27 January 2021 (2021-01-27) – present (3 years, 117 days ago)
Location	Nepal
Cause	COVID-19 pandemic in Nepal
Target	Immunisation of Nepalese against COVID-19
Organised by	Government of Nepal
Participants	1,51,72,527 people with at least one dose administered 1,12,32,683 people have been fully vaccinated
Outcome	51% of the Nepalese population has received at least one dose. 38% of Nepalese population has received full doses
Website	www.mohp.gov.np vaccine.mohp.gov.np

Part of a series on the
COVID-19 pandemic
COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths
Timeline 2019 2020 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November responses December responses 2021 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November responses December responses 2022 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November December 2023 2024
Locations By country and territory Africa Antarctica Asia Europe North America Oceania South America By conveyance Cruise ships Naval ships
International response Endemic phase Evacuations Face masks International aid Origin Lockdowns by country Misinformation by governments Fake treatments Social distancing Software Travel United Nations World Health Organization WTO IP waiver Undercounting of deaths COVID-19 apps Zero-COVID National responses Africa China European Union Germany Ghana India Ireland Netherlands New Zealand Nigeria Philippines Russia Sweden UK government US federal government Vietnam
Medical response Disease testing Breathalyzer Development Drug development Drug repurposing Public health mitigation Vaccines History Research VITT Deployment Authorizations Operation Warp Speed Misinformation and hesitancy US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V
Variants Variants of concern Alpha Beta Gamma Delta Omicron Other variants Epsilon Zeta Eta Theta Iota Kappa Lambda Mu Cluster 5 Lineage B.1.617
Economic impact and recession Arts and culture Aviation Cannabis Cinema films Disney Fashion Financial markets Food industry Food security Journalism Music Performing arts Retail Shipping Television US sportscasting programs Tourism Video games By country Canada India Ireland Malaysia New Zealand Russia UK US By sport Association football Baseball Basketball Combat sports Cricket Disc golf Gaelic games Gridiron football Ice hockey Motorsport Rugby league
Impacts Animals Alzheimer's disease patients Black people Crime Death rates by country Disability Domestic violence Emergency evacuations Education Female Environment Hospitals Language LGBT community Long-term care Media coverage Mental health symptoms Migration Military Notable deaths Other health issues Politics diplomacy Popular culture Protests Pregnancy Prisons Religion Catholic Church Hajj Science and technology Social media Strikes Suicides Telehealth Xenophobia and racism Society Ireland Malaysia New Zealand Russia UK US
COVID-19 portal
v t e

Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February.^[2] In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said "We will export vaccines taking into account the domestic demand."^[3] By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon."^[4]

Nepal approved China's Sinopharm BIBP vaccine (BBIBP-CorV) for emergency use on 15 February. The first doses arrived in Nepal on 29 March.^[2] By July, China, had provided 1.8 million doses of the Sinopharm BIBP vaccine under grant assistance, and committed to providing another 1.6 million doses. Separately, the government purchased 4 million doses in June for which delivery was expected to be complete in a few days and was expected to purchase another 6 million doses in July.^[5]

About 1.52 million doses of single dose Janssen vaccine (Johnson & Johnson) arrived on July as aid from the United States.^[6] Similarly, Ambassador Berry assured that the U.S. had prioritized additional vaccine assistance to Nepal realizing the need.^[7] Nepal on 25 October 2021 received 100,620 doses of Pfizer-BioNtech COVID-19 vaccine provided by the United States through COVAX.^[8]

Nepal is set to receive 1.6 million doses of single dose Oxford AstraZeneca as aid from Japan.^[9] Nepal has requested additional 3 lakhs vaccine dosage from Bhutan which is under consideration.^[10]